When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of ...

What resources would you recommend for those looking to deepen their understanding of building GenAI-powered apps and prepare ...

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, ...

Vertex Energy, Inc. (NASDAQ:VTNR) ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, today announced that Doug Haugh is stepping down from his role ...

Haystack is an easy open-source framework for building RAG pipelines and LLM-powered applications, and the foundation for a ...

Given all these factors, it seems reasonable to assume that Casgevy could grab at least a decent share, perhaps 20% of its ...

Ginkgo Bioworks introduces a protein large language model and API, developed with Google Cloud, to streamline drug discovery ...

Solution providers ‘are building large business opportunities ... revealed the enhancements in a Thursday blog post about its Vertex AI machine learning platform as the battle for GenAI ...

India's semiconductor sector, despite being home to 20-25 per cent of the global design talent, has historically lacked a ...